Temedica

A Day in the Alps ⛰️ Last week, for our quarterly event, the Temedica team swapped office life for a hike in the Alps. Nearly 100 team members took part, enjoying the stunning scenery and the chance to connect outside of work. Obviously, as a Bavarian company, it's practically our duty to introduce our employees to the mountains, the hikes and cozy huts to stop by for some delicious Kaiserschmarren, Sauerkraut, and dumplings. But make no mistake: We sweated! Ultimately, we reached the top and enjoyed a well-deserved lunch with breathtaking views. These outings are essential, reminding us of the importance of taking a step back to appreciate both nature and each other. Looking forward to our next quarterly adventure! 🌄🥾 #workplaceculture #teambuilding #discovertemedica #lifeattemedica #healthinsights

Temedica’s Flagship Event Returns to Munich for 2024! 🥁 👉https://lnkd.in/dPNRa4nz We are SO excited to announce that '𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀', Temedica's signature event will make its grand return to 𝗠𝘂𝗻𝗶𝗰𝗵 𝗼𝗻 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟭𝟱, 𝟮𝟬𝟮𝟰! Get ready to dive deep with the brightest minds in the healthcare ecosystem as we further explore the untapped potential of Real-World Evidence and AI. This year, our focus sharpens on how advanced data handling and AI are turning healthcare information into strategic goldmines. Additionally, once again, a giant tech industry leader will be joining us — stay tuned as we count down to the big reveal next week! 🚀 We'll be sharing more information on our speakers and event agenda soon. In the meantime, if you're a leader, researcher, technologist, or data scientist in life sciences, now is the time to start securing your tickets! We can't wait to welcome you to Munich this October! It's going to be legendary! #FutureOfHealthInsights2024 #RealWorldEvidence #AIinHealthcare #TemedicaEvent #HealthcareInnovation

Are You Eager to Shape the Future of Healthcare? Join us as a B2B Content Marketing Manager (f/d/m) and bring your expertise to a team that's dedicated to personalizing healthcare 💙 Discover this exciting opportunity and others on our careers page and help us deliver impactful health insights through advanced technology. Explore our open roles here 👉 https://lnkd.in/d7UhKaqK #temedicacareers #marketingjobs #healthtech #healthcareinnovation

Real-World Insights: A Catalyst for Effective Patient Care! 📊 🌐 It’s a stark reality: around 50% of Multiple Sclerosis (MS) patients report suffering from depression. This was a key finding in our study conducted with Temedica's Brisa app, which provided insights into the usage patterns of medication and the prevalence of symptoms among MS patients. This unexpected finding underscores the value of real-world insights. It provides a deeper understanding of patient characteristics, prevalent symptoms, and medication usage patterns, all of which are relevant to the entire healthcare sector. At Temedica, we enhance these insights through our Permea Solutions, integrating diverse data sources to deliver a comprehensive 360° view of patient experiences to all stakeholders of the healthcare system. 👉 For more on the study and how to harness these insights, download our whitepaper today: https://lnkd.in/diHXNwZj #realworldevidence #patientreportedoutcomes #PRO #patientengagement #healthcareinnovation

🚨 Last chance to register for the latest Multiple Sclerosis (MS) treatment trends🚨 Join us tomorrow at 18:00 CET for an exclusive live webinar in partnership with Sandoz and esteemed leading researcher Prof. Dr. med. Tjalf Ziemssen from Dresden University Hospital, focusing on the rise of the 'hit hard and early' treatment approach for MS in Germany. Highlights will include: ✅ 𝗗𝗿𝘂𝗴 𝗖𝗮𝘁𝗲𝗴𝗼𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀: Discover the shift from category 1 to category 3 high-efficacy MS medications. ✅ 𝗘𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: Learn from Prof. Dr. med. Ziemssen about how these changes are improving patient outcomes. ✅ 𝗘𝗻𝗴𝗮𝗴𝗲 𝘄𝗶𝘁𝗵 𝗘𝘅𝗽𝗲𝗿𝘁𝘀: An opportunity to interact directly with pioneers in MS research and enhance your professional knowledge. Register now 👉 https://lnkd.in/dUH3WxnY Looking forward to seeing you tomorrow! #innovativepartnerships #multiplesclerosis #treatmenttrends #patientcare

Announcing the Launch of 'Retinora': Our New Patient Companion App in Collaboration with Roche Germany 📱🎉 This week is an exciting one at Temedica, as we celebrate the launch of 'Retinora,' our new patient companion app developed in collaboration with Roche Germany. Designed to empower individuals managing macular diseases, 'Retinora' builds on the success of our first joint app 'Brisa!, which was developed to support Multiple Sclerosis patients. 'Retinora' is crafted with input from both patients and healthcare professionals, offering features that enhance daily living and deepen understanding of the disease. Its intuitive tools, such as streamlined appointment scheduling and detailed disease information, empower users to take charge of their health and improve their quality of life. We're very proud to take another significant step towards personalizing healthcare with 'Retinora'! For more details about our innovative app and how it can assist in managing macular diseases, check our latest announcement 👉 https://lnkd.in/dQzb5F7w #healthcareinnovation #digitalhealth #realworldevidence #chronicdiseasemanagement

Build your own indication-specific patient companion app & speed time to therapy! 🚀 👉 https://lnkd.in/dGnEaTnU Did you know? Indication-specific apps are a vital component of our Real-World Evidence ecosystem 🌐📲 We build strong, trusting patient communities around these apps, maintaining a remarkable 70% opt-in rate for anonymized data sharing. This enriches both our and our partners' insights and guides the evolution of our solutions. By actively engaging and listening to our users, our apps transcend their functional roles to become trusted companions in their healthcare journey. This approach leads to direct patient impact: enhancements tailored to meet specific needs increase both satisfaction and effectiveness. Continuous updates, informed by real-time feedback, improve disease management and enhance our apps' capacity to address specific challenges. Moreover, the engagement and responsiveness of our patient communities boost the quality and relevance of the data we collect, facilitating more effective decision-making. 📊 Interested in this patient-centric approach? Visit our website and connect with our experts!👆 We’re proven and fast, launching comprehensive indication-specific patient apps in just a few months! #apptechnology #realworlddata #patientcentricity #healthcareinnovation

Research Findings Hot Off the Press! 👉 https://lnkd.in/dvsCyXNC Join us and Sandoz 𝗝𝘂𝗻𝗲 𝟭𝟴 𝗮𝘁 𝟭𝟴:𝟬𝟬 𝗖𝗘𝗧 as we launch our joint webinar series, co-hosted with leading Multiple Sclerosis (MS) researchers. This series will reveal brand-new and exclusive results from our collaborative research efforts. The first episode features Prof. Dr. med. Tjalf Ziemssen, Head of the Center for Clinical Neurosciences & Professor of Clinical Neurosciences at Dresden University Hospital, with whom we will delve into: 1️⃣ 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝗠𝗦 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: Learn about research findings that challenge traditional methods. 2️⃣ 𝗟𝗮𝘁𝗲𝘀𝘁 𝗧𝗿𝗲𝗻𝗱𝘀 𝗶𝗻 𝗗𝗿𝘂𝗴 𝗣𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻: Explore the rise of high-efficacy medications and their profound impact on MS treatment. 3️⃣ 𝗟𝗶𝘃𝗲 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻: Engage with top MS researchers and experts in an interactive panel. Don’t miss out, it's going to be insightful! Secure your spot now! #multiplesclerosisresearch #MStreatment #innovativepartnerships #sandoz #healthcareinnovation

Up Next: Power Session on Enhancing Your Patient Journey! Join Us! 🚀 👉 https://lnkd.in/e8y6U7jY Did you know that nearly half of all drug launches don't achieve their potential because they miss a proper understanding of the patient journey? Join us on 𝗝𝘂𝗻𝗲 𝟭𝟯 𝗮𝘁 𝟭𝟭:𝟬𝟬 𝗖𝗘𝗧 for the next episode from our "First Time Leading a Drug Launch" series. Dive deep into how to gather and analyze Patient-Generated Data with industry experts Ludger Kempf and PD Dr. med Benjamin Friedrich. You will learn how to: ✅ 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝗚𝗮𝗽𝘀: Explore how traditional methods might be failing to capture the full patient perspective. ✅ 𝗛𝗮𝗿𝗻𝗲𝘀𝘀 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗗𝗮𝘁𝗮: Gain insights on how to effectively collect, analyze, and integrate direct, patient-generated data to enhance your drug’s market success. Looking for tangible how-tos? 𝗦𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁 𝘁𝗼𝗱𝗮𝘆 and transform your understanding of effective drug launch strategies! 📝 #druglaunch #patientjourney #patientinsights #realworldevidence #healthcareinnovation

Temedica and Sandoz Join Forces at Digi-Tech Pharma & AI 2024 🤝🚀 Good partnerships are cultivated over time and thrive on groundbreaking innovations. At this year's Digi-Tech Pharma & AI our collaboration with Sandoz was front and center. PD Dr. med Benjamin Friedrich from Temedica and Dan Ma from Sandoz delivered an insightful presentation on 'Corporate start-up partnerships in digital health', emphasizing the impact of our partnership on advancing healthcare. Key Takeaways: 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲: Our partnership leverages real-world data to enhance Multiple Sclerosis treatment methodologies. 𝗜𝗺𝗽𝗮𝗰𝘁𝗳𝘂𝗹 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗣𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀: Together, we're pushing forward high-impact research publications that address complex healthcare needs. 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀: Our collaborative efforts are setting new standards, influencing treatment guidelines, and improving patient outcomes. 👉 Dan Ma, here's to transforming the future of healthcare through innovative partnerships! Thank you for an inspiring journey so far, with much ahead of us! #temedica #sandoz #innovativepartnership #realworldevidence #strategicpublications #DigiTechPharma2024